Works matching DE "ONCHOCERCIASIS treatment"


Results: 121
    1
    2
    3
    4
    5
    6

    Comparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot Trial.

    Published in:
    PLoS Neglected Tropical Diseases, 2017, v. 11, n. 1, p. 1, doi. 10.1371/journal.pntd.0005156
    By:
    • Ricchiuto, Arcangelo;
    • Arriens, Sandra;
    • Dubben, Bettina;
    • Klarmann-Schulz, Ute;
    • Hoerauf, Achim;
    • Specht, Sabine;
    • Fimmers, Rolf;
    • Batsa, Linda;
    • Osei-Mensah, Jubin;
    • Mubarik, Yusif;
    • Debrah, Alexander Yaw;
    • Ayisi-Boateng, Nana Kwame;
    • Konadu, Peter;
    • Ford, Louise;
    • Taylor, Mark
    Publication type:
    Article
    8
    9
    10
    11

    Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon.

    Published in:
    Parasites & Vectors, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13071-019-3345-7
    By:
    • Boullé, Charlotte;
    • Njamnshi, Alfred K.;
    • Dema, Fidèle;
    • Mengnjo, Michel K.;
    • Siewe Fodjo, Joseph Nelson;
    • Bissek, Anne-Cécile Zoung-Kanyi;
    • Suykerbuyk, Patrick;
    • Lenou-Nanga, Cédric G.;
    • Nana-Djeunga, Hugues C.;
    • Kamgno, Joseph;
    • Chesnais, Cédric B.;
    • Boussinesq, Michel;
    • Colebunders, Robert
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    26
    27
    28
    29
    30
    31
    32

    Control of River Blindness.

    Published in:
    JAMA: Journal of the American Medical Association, 2013, v. 309, n. 11, p. 1101, doi. 10.1001/jama.2013.2398
    Publication type:
    Article
    33
    34
    35

    Doxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial.

    Published in:
    Clinical Infectious Diseases, 2015, v. 61, n. 4, p. 517, doi. 10.1093/cid/civ363
    By:
    • Debrah, Alexander Yaw;
    • Specht, Sabine;
    • Klarmann-Schulz, Ute;
    • Batsa, Linda;
    • Mand, Sabine;
    • Marfo-Debrekyei, Yeboah;
    • Fimmers, Rolf;
    • Dubben, Bettina;
    • Kwarteng, Alexander;
    • Osei-Atweneboana, Mike;
    • Boakye, Daniel;
    • Ricchiuto, Arcangelo;
    • Büttner, Marcelle;
    • Adjei, Ohene;
    • Mackenzie, Charles D.;
    • Hoerauf, Achim
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    46
    47

    Response to the Letter to the Editor by Eberhard et al.

    Published in:
    2017
    By:
    • Bottomley, Christian;
    • Isham, Valerie;
    • Vivas-Martínez, Sarai;
    • Kuesel, Annette C.;
    • Attah, Simon K.;
    • Opoku, Nicholas O.;
    • Lustigman, Sara;
    • Walker, Martin;
    • Basáñez, Maria-Gloria
    Publication type:
    Letter to the Editor
    48

    Current Topics.

    Published in:
    WHO Drug Information, 2009, v. 23, n. 3, p. 225
    Publication type:
    Article
    49
    50